- Home
- HOWL vs SNAL Comparison
HOWL vs SNAL Comparison
Compare HOWL & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOWL | SNAL |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.5M | 33.2M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | HOWL | SNAL |
|---|---|---|
| Price | $0.69 | $0.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | ★ 796.4K | 29.3K |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $82,330,445.00 |
| Revenue This Year | N/A | $13.87 |
| Revenue Next Year | N/A | $26.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $0.64 |
| 52 Week High | $2.38 | $3.42 |
Technical Indicators
Market Signals| Indicator | HOWL | SNAL |
|---|---|---|
| Relative Strength Index (RSI) | 32.09 | 42.70 |
| Support Level | $0.56 | $0.85 |
| Resistance Level | $1.20 | $0.96 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 19.49 | 20.59 |
Price Performance
Historical ComparisonAbout HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.